140 related articles for article (PubMed ID: 25419632)
1. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells.
Wang X; Wang C; Zhang L; Li Y; Wang S; Wang J; Yuan C; Niu J; Wang C; Lu G
Anticancer Drugs; 2015 Feb; 26(2):210-23. PubMed ID: 25419632
[TBL] [Abstract][Full Text] [Related]
2. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
[TBL] [Abstract][Full Text] [Related]
3. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
[TBL] [Abstract][Full Text] [Related]
4. Paris saponin VII from trillium tschonoskii reverses multidrug resistance of adriamycin-resistant MCF-7/ADR cells via P-glycoprotein inhibition and apoptosis augmentation.
Li Y; Fan L; Sun Y; Miao X; Zhang F; Meng J; Han J; Zhang D; Zhang R; Yue Z; Mei Q
J Ethnopharmacol; 2014 Jul; 154(3):728-34. PubMed ID: 24818584
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
[TBL] [Abstract][Full Text] [Related]
6. Prevention of pulmonary fibrosis with salvianolic acid a by inducing fibroblast cell cycle arrest and promoting apoptosis.
Pan Y; Fu H; Kong Q; Xiao Y; Shou Q; Chen H; Ke Y; Chen M
J Ethnopharmacol; 2014 Sep; 155(3):1589-96. PubMed ID: 25102244
[TBL] [Abstract][Full Text] [Related]
7. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo.
Xu HB; Shen ZL; Fu J; Xu LZ
Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783
[TBL] [Abstract][Full Text] [Related]
8. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
[TBL] [Abstract][Full Text] [Related]
9. Salvianic acid A protects L-02 cells against γ-irradiation-induced apoptosis via the scavenging of reactive oxygen species.
Guo J; Zhang Y; Zeng L; Liu J; Liang J; Guo G
Environ Toxicol Pharmacol; 2013 Jan; 35(1):117-30. PubMed ID: 23274418
[TBL] [Abstract][Full Text] [Related]
10. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM.
Cen J; Qi Y; Tao YF; Deng Y; Fang WR; Li YM; Zhang LY; Huang WL
Eur J Pharmacol; 2010 Nov; 647(1-3):21-30. PubMed ID: 20816813
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
[TBL] [Abstract][Full Text] [Related]
12. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
Banerjee K; Biswas MK; Choudhuri SK
J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T
Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T
Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic compounds from the fruits of Uapaca togoensis towards multifactorial drug-resistant cancer cells.
Kuete V; Sandjo LP; Seukep JA; Zeino M; Mbaveng AT; Ngadjui B; Efferth T
Planta Med; 2015 Jan; 81(1):32-8. PubMed ID: 25473921
[TBL] [Abstract][Full Text] [Related]
20. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
